Emerging data suggest Retatru tide , a dual stimulator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , could represent a significant advancement for weight management . Initial patient tests have indicated impressive decreases in visceral mass , potentially exceeding other weight-loss treatments. Nevertheless , more assessme